# A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

> **NCT01103050** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 60 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** QAV680 + Cetirizine Placebo
- **DRUG:** QAV680 + Cetirizine
- **DRUG:** Cetirizine + QAV680 Placebo
- **DRUG:** QAV680 Placebo + Cetirizine Placebo

## Key facts

- **NCT ID:** NCT01103050
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-22
- **Primary completion:** 2010-07-28
- **Final completion:** 2010-07-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103050, "A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01103050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*